首页> 外文OA文献 >Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)

【2h】

Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)

机译：年龄作为连续变量对来自中国淋巴瘤的鼻腔型NK / T细胞淋巴瘤（CLCG）患者患者的生存结果和治疗选择

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Wei-Xin Liu; Mei Shi; Hang Su; Ying Wang; Xia He; Li-Ming Xu; Zhi-Yong Yuan; Li-Ling Zhang; Gang Wu; Bao-Lin Qu; Li-Ting Qian; Xiao-Rong Hou; Fu-Quan Zhang; Yu-Jing Zhang; Yuan Zhu; Jian-Zhong Cao; Sheng-Min Lan; Jun-Xin Wu; Tao Wu; Su-Yu Zhu; Shu-Nan Qi; Yong Yang; Bo Chen; Ye-Xiong Li;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG) [J] . Shu-Nan Qi, Li-Ming Xu, Zhi-Yong Yuan, Leukemia and lymphoma . 2019,第11a12期

机译：原发性肿瘤侵袭对现代化疗时代外鼻型NK / T细胞淋巴瘤治疗和存活的影响：中国淋巴瘤协作组的多中心研究（CLCG）
2. Curability of Radiotherapy in Elderly Patients with Earlystage Extranodal Nasal-type NK/T-cell Lymphoma: A Multicenter Study from the China Lymphoma Collaborative Group (CLCG) [J] . Chen B., Zhu S. Y., Shi M., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：老年早期患者放射治疗的可固化性外鼻鼻型NK / T细胞淋巴瘤：中国淋巴瘤协作组的多中心研究（CLCG）
3. Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG) [J] . Xiu-Wen Deng, Jun-Xin Wu, Tao Wu, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2018,第1期

机译：在早期外鼻型NK / T细胞淋巴瘤中完全反应含天冬酰胺酶的化疗后完全反应，放射疗法是必不可少的：中国淋巴瘤协作组的多中心研究（CLCG）
4. New biologic agents for the treatment of cutaneous T-cell lymphoma. [C] . Vittorio CC, Junkins Hopkins JM, McGinnis KS, World Congress on Cancers of the Skin . 2002

机译：用于治疗皮肤T细胞淋巴瘤的新生物剂。
5. Prognostic Biomarkers for Diffuse Large B Cell Lymphoma Patient Survival after Treatment with Chemotherapy: A Retrospective Analysis of 88 Cases [D] . Bushra, Hamama tul. 2019

机译：弥漫性大B细胞淋巴瘤化疗后患者生存的预后生物标志物：88例回顾性分析
6. Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG) [O] . Wei-Xin Liu, Mei Shi, Hang Su, 2019

机译：年龄作为连续变量对中国淋巴瘤协作组（CLCG）结外鼻型NK / T细胞淋巴瘤患者生存结局和治疗选择的影响
7. Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study [O] . Yong Yang, Ying Wang, Xin Liu, 2020

机译：24个月的无进展生存率和随后的骨髓NK / T细胞淋巴瘤患者的存活：中国淋巴瘤协作组（CLCG）研究

Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)

著录项

相似文献

相关主题

期刊订阅